Nature Communications (Mar 2021)

Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer

  • Alexandre F. Aissa,
  • Abul B. M. M. K. Islam,
  • Majd M. Ariss,
  • Cammille C. Go,
  • Alexandra E. Rader,
  • Ryan D. Conrardy,
  • Alexa M. Gajda,
  • Carlota Rubio-Perez,
  • Klara Valyi-Nagy,
  • Mary Pasquinelli,
  • Lawrence E. Feldman,
  • Stefan J. Green,
  • Nuria Lopez-Bigas,
  • Maxim V. Frolov,
  • Elizaveta V. Benevolenskaya

DOI
https://doi.org/10.1038/s41467-021-21884-z
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 25

Abstract

Read online

It has been proposed that resistance to targeted therapies in non-small cell lung carcinoma (NSCLC) is due to a nonhomogeneous cell population. Here the authors analyse preclinical NSCLC models using single-cell RNA-seq and identify drug tolerant cell states and subpopulations, as well as associated genes.